Voyager Therapeutics Inc/ US92915B1061 /
6/10/2024 10:00:00 PM | Chg. +0.3500 | Volume | Bid12:15:35 AM | Ask12:15:35 AM | High | Low |
---|---|---|---|---|---|---|
8.7700USD | +4.16% | 461,877 Turnover: 2.86 mill. |
8.2000Bid Size: 100 | 8.6000Ask Size: 6,900 | 8.7800 | 8.2000 |
GlobeNewswire
6/4
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment o...
GlobeNewswire
5/16
Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 f...
GlobeNewswire
5/8
Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene The...
GlobeNewswire
4/22
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Th...
GlobeNewswire
4/16
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration ...
GlobeNewswire
3/26
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
3/13
Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
GlobeNewswire
2/28
Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
GlobeNewswire
2/26
Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Atax...
GlobeNewswire
2/20
Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for A...
GlobeNewswire
1/3
Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire
1/2
Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Ad...
GlobeNewswire
12/6/2023
Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Scler...
GlobeNewswire
12/1/2023
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
GlobeNewswire
11/6/2023
Voyager Therapeutics Reports Third Quarter 2023 Financial and Operating Results
GlobeNewswire
10/30/2023
Voyager Therapeutics Announces Third Quarter 2023 Conference Call and Webcast